Hibiscus

Wadatacce

• Yiwuwar tasiri ga ...
• Evidencearancin shaida don kimanta inganci don ...
• Kariya & Gargaɗi na Musamman:

Hibiscus tsire-tsire ne. Ana amfani da furanni da sauran sassan shuka don yin magani.

Mutane suna amfani da hibiscus don hawan jini, hawan cholesterol, don haɓaka samar da ruwan nono, da sauran wasu sharuɗɗa, amma babu kyakkyawar shaidar kimiyya don tallafawa yawancin waɗannan amfani.

Magunguna na Compwararren Bayanan Bayanai ƙimar tasiri bisa ga shaidar kimiyya bisa ga mizani mai zuwa: Inganci, Mai yuwuwa Mai Yiwuwa, Yiwuwar Tasiri, Yiwuwar Mara Inganci, Mai yiwuwa Mara Inganci, Mara Inganci, da suarancin Shaida don Rate.

Effectivenessimar tasiri don HIBISCUS sune kamar haka:

Yiwuwar tasiri ga ...

• Hawan jini. Mafi yawan binciken farko ya nuna cewa shan shayin hibiscus tsawon makonni 2-6 yana rage hauhawar jini da ɗan ƙarami a cikin mutanen da ke da jinin al'ada ko hawan jini. Wasu bincike na farko sun nuna cewa shan shayin hibiscus na iya zama mai tasiri kamar magungunan da ake amfani da su kuma ya fi tasirin maganin hydrochlorothiazide don rage hawan jini ga mutanen da ke da hawan jini kaɗan.

Evidencearancin shaida don kimanta inganci don ...

• Matakan da ba na al'ada ba na cholesterol ko ƙwayar jini (dyslipidemia). Wasu bincike na farko sun nuna cewa shan shayin hibiscus ko shan hibiscus ta baki zai iya rage matakan cholesterol da sauran kitse na jini a cikin mutane masu fama da cuta irin na ciwon sukari. Koyaya, wasu bincike sun nuna cewa hibiscus baya inganta matakan cholesterol a cikin mutanen da ke da babban cholesterol.
• Cututtuka na koda, mafitsara, ko mafitsara (cututtukan urinary ko UTIs). Binciken farko da aka gudanar ya gano cewa mutanen da ke dauke da bututun fitsari wadanda ke zaune a wuraren kulawa na tsawon lokaci wadanda ke shan shayin hibiscus suna da kaso 36% na yiwuwar kamuwa da cutar yoyon fitsari idan aka kwatanta da wadanda ba sa shan shayi.
• Sanyi.
• Kiba.
• Maƙarƙashiya.
• Rike ruwa.
• Ciwon zuciya.
• Cutar ciki.
• Rashin ci.
• Ciwon jijiya.
• Sauran yanayi.

Ana buƙatar ƙarin shaida don kimanta hibiscus don waɗannan amfani.

Ruwan ‘ya’yan itace a cikin hibiscus na iya aiki kamar na laxative. Wasu masu bincike suna tunanin cewa wasu sinadarai a cikin hibiscus na iya iya rage hawan jini; rage matakan sukari da mai a cikin jini; rage spasms a ciki, hanji, da mahaifa; rage kumburi; kuma suyi aiki kamar maganin kashe kwayoyin cuta da tsutsotsi.

Lokacin shan ta bakin: Hibiscus shine LAFIYA LAFIYA ga yawancin mutane lokacin da aka cinye su cikin adadin abinci. Yana da MALAM LAFIYA lokacin da aka sha bakin ta daidai cikin adadin magani. Sakamakon sakamako na hibiscus baƙon abu bane amma yana iya haɗawa da ɓacin rai na ɗan lokaci ko ciwo, gas, maƙarƙashiya, tashin zuciya, fitsari mai zafi, ciwon kai, ringi a kunnuwa, ko raunin jiki.

Kariya & Gargaɗi na Musamman:

Ciki da shan nono: Hibiscus shine YIWU KA KIYAYE lokacin da aka sha baki da yawa azaman magani.

Ciwon suga: Hibiscus na iya rage matakan sukarin jini. Yawan magungunan ku na ciwon sukari na iya buƙatar daidaitawa ta hanyar mai ba da lafiyar ku.

Pressureananan hawan jini: Hibiscus na iya rage hawan jini. A ka'idar, shan hibiscus na iya sa cutar hawan jini tayi kasa sosai ga mutanen da ke da karfin jini.

Tiyata: Hibiscus na iya shafar matakan sikarin cikin jini, wanda ke sa sarrafa suga cikin jini ya zama da wahala yayin da bayan tiyata. Dakatar da amfani da hibiscus aƙalla makonni 2 kafin a shirya aikin tiyata.

Manjo

Kada ku ɗauki wannan haɗin.

Chloroquine (Aralen)

Shayi na Hibiscus na iya rage adadin chloroquine wanda jiki zai iya sha da amfani dashi. Shan shayin hibiscus tare da chloroquine na iya rage tasirin chloroquine. Mutanen da ke shan maganin chloroquine don magani ko rigakafin zazzabin cizon sauro ya kamata su guji kayayyakin hibiscus.

Matsakaici

Yi hankali da wannan haɗin.

Diclofenac (Voltaren, wasu)

Hibiscus na iya rage yawan diclofenac da ke cikin fitsari. Ba a san dalilin hakan ba. A ka'ida, shan hibiscus yayin shan diclofenac na iya canza matakan diclofenac a cikin jini kuma ya gyara illolinsa da illolinsa. Har sai an san ƙarin amfani da hibiscus tare da diclofenac a hankali.

Magunguna don ciwon sukari (Magungunan cututtukan siga)

Hibiscus na iya rage sukarin jini. Ana amfani da magungunan ciwon suga don rage sukarin jini. Shan hibiscus tare da magungunan ciwon sikari na iya haifar da sikarin jininka ya yi ƙasa sosai. Kula da yawan jinin ka sosai. Za a iya canza yawan adadin magungunan cutar sikari.

Wasu magunguna da ake amfani da su don ciwon suga sun haɗa da glimepiride (Amaryl), glyburide (DiaBeta, Glynase PresTab, Micronase), insulin, metformin (Glucophage), pioglitazone (Actos), rosiglitazone (Avandia), chlorpropamide (Diabinese), glipizide (Glucot) Orinase), da sauransu.

Magunguna don hawan jini (Magungunan antihypertensive)

Hibiscus na iya rage hawan jini. Shan hibiscus tare da magungunan da ake amfani da su don rage hawan jini na iya haifar da hawan jini ya yi ƙasa ƙwarai. Kada ku ɗauki hibiscus da yawa idan kuna shan magunguna don hawan jini.

Wasu magunguna don hawan jini sun hada da nifedipine (Adalat, Procardia), verapamil (Calan, Isoptin, Verelan), diltiazem (Cardizem), isradipine (DynaCirc), felodipine (Plendil), amlodipine (Norvasc), da sauransu.

Simvastatin (Zocor)

Jiki yana lalata simvastatin (Zocor) don kawar dashi. Hibiscus na iya haɓaka yadda sauri jiki ke kawar da simvastatin (Zocor). Koyaya, ba a bayyana ba idan wannan babban damuwa ne.

Orananan

Yi hankali da wannan haɗin.

Acetaminophen (Tylenol, wasu)

Shan shan hibiscus kafin shan acetaminophen na iya kara saurin saurin jikin ku na kawar da acetaminophen. Amma ana buƙatar ƙarin bayani don sanin ko wannan babban damuwa ne.

Magunguna da hanta suka canza (Cytochrome P450 1A2 (CYP1A2) substrates)

Wasu magunguna ana canza su ta hanta. Hibiscus na iya rage yadda hanta ke saurin wargaza wasu magunguna. Yin amfani da hibiscus tare da wasu magunguna waɗanda hanta ke lalata na iya ƙara tasiri da tasirin wasu daga cikin waɗannan magunguna.
Wasu magunguna da hanta ta canza sun hada da amitriptyline (Elavil), haloperidol (Haldol), ondansetron (Zofran), propranolol (Inderal), theophylline (Theo-Dur, wasu), verapamil (Calan, Isoptin, wasu), da sauransu.

Magunguna sun canza ta hanta (Cytochrome P450 2A6 (CYP2A6) substrates)

Wasu magunguna ana canza su ta hanta. Hibiscus na iya rage yadda hanta ke saurin wargaza wasu magunguna. Yin amfani da hibiscus tare da wasu magunguna waɗanda hanta ke lalata na iya ƙara tasiri da tasirin wasu daga cikin waɗannan magunguna.
Wasu magunguna da hanta ta canza sun hada da nicotine, chlormethiazole (Heminevrin), coumarin, methoxyflurane (Penthrox), halothane (Fluothane), valproic acid (Depacon), disulfiram (Antabuse), da sauransu.

Magunguna sun canza ta hanta (Cytochrome P450 2B6 (CYP2B6) substrates)

Wasu magunguna ana canza su ta hanta. Hibiscus na iya rage yadda hanta ke saurin wargaza wasu magunguna. Yin amfani da hibiscus tare da wasu magunguna waɗanda hanta ke farfasawa na iya ƙara tasiri da tasirin wasu daga cikin waɗannan magunguna.
Wasu magunguna da hanta ta canza sun hada da ketamine (Ketalar), phenobarbital, orphenadrine (Norflex), secobarbital (Seconal), da dexamethasone (Decadron).

Magunguna da hanta suka canza (Cytochrome P450 2C19 (CYP2C19) substrates)

Wasu magunguna ana canza su ta hanta. Hibiscus na iya rage yadda hanta ke saurin wargaza wasu magunguna. Yin amfani da hibiscus tare da wasu magunguna waɗanda hanta ke farfasawa na iya ƙara tasiri da tasirin wasu daga cikin waɗannan magunguna.
Wasu magunguna da hanta ta canza sun hada da proton pump inhibitors wadanda suka hada da omeprazole (Prilosec), lansoprazole (Prevacid), da pantoprazole (Protonix); diazepam (Valium); carisoprodol (Soma); nelfinavir (Viracept); da sauransu.

Magunguna sun canza ta hanta (Cytochrome P450 2C8 (CYP2C8) substrates)

Wasu magunguna ana canza su ta hanta. Hibiscus na iya rage yadda hanta ke saurin wargaza wasu magunguna. Yin amfani da hibiscus tare da wasu magunguna waɗanda hanta ke farfasawa na iya ƙara tasiri da tasirin wasu daga cikin waɗannan magunguna.
Wasu magunguna da hanta suka canza sun haɗa da amiodarone (Cardarone), paclitaxel (Taxol); kwayoyin cututtukan cututtukan ƙwayoyin cuta (NSAIDs) irin su diclofenac (Cataflam, Voltaren) da ibuprofen (Motrin); rosiglitazone (Avandia); da sauransu.

Magunguna sun canza ta hanta (Cytochrome P450 2C9 (CYP2C9) substrates)

Wasu magunguna ana canza su ta hanta. Hibiscus na iya rage yadda hanta ke saurin wargaza wasu magunguna. Yin amfani da hibiscus tare da wasu magunguna waɗanda hanta ke farfasawa na iya ƙara tasiri da tasirin wasu daga cikin waɗannan magunguna.
Wasu magungunan da hanta ta canza sun hada da nonsteroidal anti-inflammatory anti-inflammatory drugs (NSAIDs) kamar diclofenac (Cataflam, Voltaren), ibuprofen (Motrin), meloxicam (Mobic), da piroxicam (Feldene); celecoxib (Celebrex); amitriptyline (Elavil); warfarin (Coumadin); glipizide (Glucotrol); losartan (Cozaar); da sauransu.

Magunguna sun canza ta hanta (Cytochrome P450 2D6 (CYP2D6) substrates)

Wasu magunguna ana canza su ta hanta. Hibiscus na iya rage yadda hanta ke saurin wargaza wasu magunguna. Yin amfani da hibiscus tare da wasu magunguna waɗanda hanta ke farfasawa na iya ƙara tasiri da tasirin wasu daga cikin waɗannan magunguna.
Wasu magunguna da hanta ta canza sun hada da amitriptyline (Elavil), codeine, desipramine (Norpramin), flecainide (Tambocor), haloperidol (Haldol), imipramine (Tofranil), metoprolol (Lopressor, Toprol XL), ondansetron (Zofran), paroxetil ), risperidone (Risperdal), tramadol (Ultram), venlafaxine (Effexor), da sauransu.

Magunguna sun canza ta hanta (Cytochrome P450 2E1 (CYP2E1) substrates)

Wasu magunguna ana canza su ta hanta. Hibiscus na iya rage yadda hanta ke saurin wargaza wasu magunguna. Yin amfani da hibiscus tare da wasu magunguna waɗanda hanta ke farfasawa na iya ƙara tasiri da tasirin wasu daga cikin waɗannan magunguna.
Wasu magungunan da hanta ta canza sun hada da acetaminophen, chlorzoxazone (Parafon Forte), ethanol, theophylline, da kuma maganin kashe kuzari irin su enflurane (Ethrane), halothane (Fluothane), isoflurane (Forane), methoxyflurane (Penthrane).

Magunguna da hanta suka canza (Cytochrome P450 3A4 (CYP3A4) substrates)

Wasu magunguna ana canza su ta hanta. Hibiscus na iya rage yadda hanta ke saurin wargaza wasu magunguna. Yin amfani da hibiscus tare da wasu magunguna waɗanda hanta ke farfasawa na iya ƙara tasiri da tasirin wasu daga cikin waɗannan magunguna.
Wasu magunguna da hanta ta canza sun hada da alprazolam (Xanax), amlodipine (Norvasc), clarithromycin (Biaxin), cyclosporine (Sandimmune), erythromycin, lovastatin (Mevacor), ketoconazole (Nizoral), itraconazole (Sporanox), trixof) (Halcion), verapamil (Calan, Isoptin) da sauransu da yawa.

Ganye da kari waɗanda zasu iya rage hawan jini

Hibiscus na iya rage hawan jini. Amfani da shi tare da sauran ganyayyaki da kari waɗanda ke da wannan tasirin na iya ƙara haɗarin saukar da hawan jini ƙasa da ƙasa. Wasu daga cikin wadannan kayayyakin sun hada da andrographis, casein peptides, cat's claw, coenzyme Q-10, man kifi, L-arginine, lycium, stinging nettle, theanine, da sauransu.

Ganye da kari waɗanda zasu iya rage sukarin jini

Hibiscus na iya rage matakan sukarin jini. Shan shi tare da sauran ganyayyaki da kari wanda zai iya rage suga cikin jini na iya kara barazanar suga cikin jini yayi kasa sosai. Wasu ganyayyaki da kari wadanda zasu iya rage suga cikin jini sun hada da alpha-lipoic acid, melon melon, chromium, ta shedan, fenugreek, tafarnuwa, guar gum, kirinjin doki, Panax ginseng, psyllium, Siberian ginseng, da sauransu.

Vitamin B12

Hibiscus na iya haɓaka shayar bitamin B12 a ciki da hanji. Wannan na iya haɓaka sakamako da illa na bitamin B12. Amma tunda bitamin B12 ana ɗaukarsa amintacce, koda a cikin ƙananan allurai, wannan ma'amala mai yiwuwa ba babban damuwa bane.

Babu sanannun hulɗa da abinci.

An yi nazarin ƙwayoyi masu zuwa a cikin binciken kimiyya:

MAGABATA

DA BAKI:

• Don hawan jini: An yi amfani da shayin Hibiscus wanda aka sanya ta ƙara gram 1.25-20 ko 150 mg / kg na hibiscus zuwa 150 mL zuwa 1000 mL na ruwan zãfi. Ana shayin shayin na tsawon minti 10-30 kuma ana shan sau daya zuwa uku a kullum na tsawon makonni 2-6.

Abelmoschus Cruentus, Agua de Jamaica, Ambashthaki, Bissap, Erragogu, Flor de Jamaica, Florida cranberry, Furcaria Sabdariffa, Gongura, Groseille de Guinée, Guinea Sorrel, Hibisco, Hibiscus Calyx, Hibiscus Cruentus, Hibiscus Fraternus, Hibisfa Jamaicadar, Hibisfa Sorrel, Karkade, Karkadé, Lo Shen, Oseille de Guinée, Oseille Rouge, Pulicha Keerai, Red Sorrel, Red Tea, Rosa de Jamaica, Rosella, Roselle, Sabdariffa Rubra Sour Tea, Sudan Tea, Te de Jamaica, Thé Rose d'Abyssinie , Thé Rouge, Zobo, Zobo Tea.

Don ƙarin koyo game da yadda aka rubuta wannan labarin, da fatan za a duba Magunguna na Compwararren Bayanan Bayanai hanya.

1. Barletta C, Paccone M, Uccello N, et al. Inganci na karin abincin Acidif tare da kula da rikitarwa UTIs a cikin mata: binciken kulawa na matukin jirgi. Minerva Ginecol. 2020; 72: 70-74. Duba m.
2. Milandri R, Maltagliati M, Bocchialini T, et al. Amfani da D-mannose, Hibiscus sabdariffa da Lactobacillus maganin tsire-tsire don rigakafin abubuwan da ke haifar da cututtuka bayan binciken urodynamic. Urologia 2019; 86: 122-125. Duba m.
3. Cai T, Tamanini I, Cocci A, et al. Xyloglucan, hibiscus da propolis don rage bayyanar cututtuka da maganin rigakafi a cikin UTI na yau da kullun: nazari mai zuwa. Microbiol na gaba. 2019; 14: 1013-1021. Duba m.
4. Al-Anbaki M, Nogueira RC, Cavin AL, et al. Yin maganin hauhawar jini wanda ba a sarrafa shi ba tare da Hibiscus sabdariffa lokacin da magani na yau da kullun bai isa ba: Shiga jirgin sama J madadin Karin Med. 2019; 25: 1200-1205. Duba m.
5. Abubakar SM, Ukeyima MT, Spencer JPE, Lovegrove JA. M sakamako na Hibiscus sabdariffa calyces a kan hawan jini, aiki na jijiyoyin jini, lipids na jini, biomarkers na insulin juriya da kumburi a cikin mutane. Kayan abinci. 2019; 11. yawa: E341. Duba m.
6. Herranz-López M, Olivares-Vicente M, Boix-Castejón M, Caturla N, Roche E, Micol V. Bambancin sakamako na haɗuwa da Hibiscus sabdariffa da Lippia citriodora polyphenols a cikin kiba / kiba batutuwa: Gwajin da bazuwar sarrafawa. Sci Rep. 2019; 9: 2999. Duba m.
7. Fakeye TO, Adegoke AO, Omoyeni OC, Famakinde AA. Illolin cirewar ruwa na Hibiscus sabdariffa, Linn (Malvaceae) 'Roselle' kan fitowar wani tsari na diclofenac. Phytother Res. 2007; 21: 96-8. Duba m.
8. Boix-Castejón M, Herranz-López M, Pérez Gago A, et al. Hibiscus da lemon verbena polyphenols suna tsara masu ba da abinci game da abinci a cikin batutuwa masu kiba: gwajin bazuwar sarrafawa. Abincin Abinci. 2018; 9: 3173-3184. Duba m.
9. Souirti Z, Loukili M, Soudy ID, et al. Hibiscus sabdariffa yana haɓaka haɓakar haɓakar hydroxocobalamin da ingancin asibiti a cikin ƙarancin bitamin B tare da alamun cututtukan jijiyoyi. Fundam Clin Pharmacol. 2016; 30: 568-576. Duba m.
10. Showande SJ, Adegbolagun OM, Igbinoba SI, Fakeye TO. A cikin vivo pharmacodynamic da hulɗar kantin magani na Hibiscus sabdariffa calyces haɓaka tare da simvastatin. J Clin Pharm Ther. Magani. 2017; 42: 695-703. Duba m.
11. Serban C, Sahebkar A, Ursoniu S, Andrica F, Banach M. Hanyoyin shayi mai tsami (Hibiscus sabdariffa L.) akan hauhawar jini: nazari na yau da kullun da ƙididdigar gwajin gwaji. J Hawan jini. 2015 Jun; 33: 1119-27. Duba m.
12. Sabzghabaee AM, Ataei E, Kelishadi R, Ghannadi A, Soltani R, Badri S, Shirani S. Sakamakon Hibiscus sabdariffa Calices akan Dyslipidemia a cikin Matasan Matasa: Aaramar Raba Masarauta uku. Mater Sociomed. 2013; 25: 76-9. Duba m.
13. Nwachukwu DC, Aneke E, Nwachukwu NZ, Obika LF, Nwagha UI, Eze AA. Hanyoyin Hibiscus sabdariffaon hawan jini da kuma bayanan lantarki na matsakaicin matsakaicin matsin lamba na 'yan Najeriya: Nazarin kwatankwacin hydrochlorothiazide. Neja J Clin Pract. 2015 Nuwamba-Dis; 18: 762-70. Duba m.
14. Mohagheghi A, Maghsoud S, Khashayar P, Ghazi-Khansari M. Sakamakon hibiscus sabdariffa akan bayanin lipid, creatinine, da kuma wutan lantarki: wani gwaji na asibiti. ISRN Gastroenterol. 2011; 2011: 976019. Duba m.
15. Lee CH, Kuo CY, Wang CJ, Wang CP, Lee YR, Hung CN, Lee HJ. Wani cirewar polyphenol na Hibiscus sabdariffa L. yana inganta acetaminophen-haifar da cututtukan hanta ta hanyar haɓaka mitochondrial dysfunction a cikin vivo da in vitro. Biosci Biotechnol Biochem. 2012; 76: 646-51. Duba m.
16. Johnson SS, Oyelola FT, Ari T, Juho H. In vitro ayyukan hanawa na cirewa na Hibiscus sabdariffa L. (dangin Malvaceae) akan zaɓaɓɓun tsarin cytochrome P450. Afr J Tradit Haɗa Altern Med. 2013 Apr 12; 10: 533-40. Duba m.
17. Iyare EE, Adegoke OA. Amfani da uwa na wani ruwa mai ɗaci na Hibiscus sabdariffa yayin shayarwa yana hanzarta nauyin haihuwa da jinkirta farkon balaga ga offspringa femalean mata. Niger J Physiol Sci. 2008 Jun-Dec; 23 (1-2): 89-94. Duba m.
18. Hadi A, Pourmasoumi M, Kafeshani M, Karimian J, Maracy MR, Entezari MH. Tasirin Ganyen Shayi da Shayi mai Tsami (Hibiscus sabdariffa L.) plementarin ƙari akan ressarfin damuwa da clearfin Muscle a cikin Yan wasa. J Abincin Abincin. 2017 Mayu 4; 14: 346-357. Duba m.
19. Da-Costa-Rocha I, Bonnlaender B, Sievers H, Pischel I, Heinrich M. Hibiscus sabdariffa L. - nazarin halittu da kantin magani. Abincin Abinci. 2014 Dec 15; 165: 424-43. Duba m.
20. Chou ST, Lo HY, Li CC, Cheng LC, Chou PC, Lee YC, Ho TY, Hsiang CY. Binciken tasiri da aikin na Hibiscus sabdariffa akan kamuwa da cutar yoyon fitsari da gwajin kumburin koda. J Ethnopharmacol. 2016 Disamba 24; 194: 617-625. Duba m.
21. Magina PF, Kabele-Toge B, Magina M, Chindo BA, Anwunobi PA, Isimi YC. Healingarfin warkar da rauni na kirkirar kirki daga hibiscus sabdariffa calyx. Indian J Pharm Sci. 2013 Jan; 75: 45-52. Duba m.
22. Aziz Z, Wong SY, Chong NJ. Hanyoyin Hibiscus sabdariffa L. akan maganin shafawa na jini: nazari na yau da kullun da meta-bincike. J Ethnopharmacol. 2013 Nuwamba 25; 150: 442-50. Duba m.
23. Alarcón-Alonso J, Zamilpa A, Aguilar FA, Herrera-Ruiz M, Tortoriello J, Jimenez-Ferrer E. Halin ilimin likitanci game da tasirin kwayar cutar ta Hibiscus sabdariffa Linn (Malvaceae). J Ethnopharmacol. 2012 Feb 15; 139: 751-6. Duba m.
24. Mahmoud, B. M., Ali, H. M., Homeida, M. M., da Bennett, J. L. Rage raguwa mai yawa a cikin chloroquine bioavailability biyo bayan kulawar da aka sha da kayan sha na Sudan Aradaib, Karkadi da Lemon. J.Antimicrob.Mutumi. 1994; 33: 1005-1009. Duba m.
25. Girija, V., Sharada, D., da Pushpamma, P. Bioavailability na thiamine, riboflavin da niacin daga yawancin kayan lambu masu ganye a ƙauyukan Andhra Pradesh a Indiya. Int.Jitam.Nutr.Res. 1982; 52: 9-13. Duba m.
26. Baranova, V. S., Rusina, I. F., Guseva, D. A., Prozorovskaia, N. N., Ipatova, O. M., da Kasaikina, O. T. Kimiya. Khim. 2012; 58: 712-726. Duba m.
27. Frank, T., Netzel, G., Kammerer, DR, Carle, R., Kler, A., Kriesl, E., Bitsch, I., Bitsch, R., da Netzel, M. Amfani da Hibiscus sabdariffa L. cire ruwa mai ruwa da tasiri akan tasirin antioxidant na tsari a cikin batutuwan lafiya. J Sci Abincin Abinci. 8-15-2012; 92: 2207-2218. Duba m.
28. Hernandez-Perez, F. da Herrera-Arellano, A. [Maganin amfani da maganin Hibiscus sabadariffa a cikin maganin hypercholesterolemia. Gwajin asibiti da bazuwar] Rev.Med Inst.Mex.Seguro.Soc. 2011; 49: 469-480. Duba m.
29. Gurrola-Diaz, CM, Garcia-Lopez, PM, Sanchez-Enriquez, S., Troyo-Sanroman, R., Andrade-Gonzalez, I., da Gomez-Leyva, JF Hanyoyin Hibiscus sabdariffa cire foda da magani mai kariya (abinci ) a kan bayanan lipid na marasa lafiya tare da ciwo na rayuwa (MeSy). Kwayar cutar shan magani. 2010; 17: 500-505. Duba m.
30. Wahabi, H. A., Alansary, L. A., Al-Sabban, A. H., da Glasziuo, P. Ingancin Hibiscus sabdariffa a cikin maganin hauhawar jini: nazari na yau da kullun. Kwayar cutar shan magani. 2010; 17: 83-86. Duba m.
31. Mozaffari-Khosravi, H., Jalali-Khanabadi, B. A., Afkhami-Ardekani, M., da Fatehi, F. Illolin shayi mai tsami (Hibiscus sabdariffa) a kan bayanin lipid da lipoproteins a cikin marasa lafiya da ke dauke da ciwon sukari na II. J madadin. Medaddamar da Med 2009; 15: 899-903. Duba m.
32. Mozaffari-Khosravi, H., Jalali-Khanabadi, B. A., Afkhami-Ardekani, M., Fatehi, F., da Noori-Shadkam, M. Sakamakon shayi mai tsami (Hibiscus sabdariffa) kan hauhawar jini ga marasa lafiya da ke dauke da ciwon sukari na II. J Hum. Hawan jini 2009; 23: 48-54. Duba m.
33. Herrera-Arellano, A., Miranda-Sanchez, J., Avila-Castro, P., Herrera-Alvarez, S., Jimenez-Ferrer, JE, Zamilpa, A., Roman-Ramos, R., Ponce-Monter, H., da Tortoriello, J. Sakamakon asibiti wanda aka samar dashi ta hanyar ingantaccen magani na Hibiscus sabdariffa akan marasa lafiya masu fama da hauhawar jini. Wani baƙi, makafi biyu, lisinopril sarrafawar gwajin asibiti. Planta Med 2007; 73: 6-12. Duba m.
34. Ali, B. H., Al, Wabel N., da Blunden, G. Phytochemical, ilimin hada magunguna da toxicological na Hibiscus sabdariffa L.: Wani bita. Yanayin jiki. 2005 2005; 19: 369-375. Duba m.
35. Frank, T., Janssen, M., Netzel, M., Strass, G., Kler, A., Kriesl, E., da Bitsch, I. Pharmacokinetics na anthocyanidin-3-glycosides bayan amfani da Hibiscus sabdariffa L. tsantsa . J Jarin Pharmacol 2005; 45: 203-210. Duba m.
36. Herrera-Arellano, A., Flores-Romero, S., Chavez-Soto, M. A., da Tortoriello, J. Inganci da jurewa na daidaitaccen tsantsa daga Hibiscus sabdariffa a cikin marasa lafiya da ke da matsakaita zuwa matsakaita hauhawar jini: gwajin gwaji da bazuwar asibiti. Kwayar cutar shan magani. 2004; 11: 375-382. Duba m.
37. Khader, V. da Rama, S. Sakamakon balaga akan abun macromineral na zababbun ganyayen ganye. Asia Pac.J.Clin.Nutr. 2003; 12: 45-49. Duba m.
38. Freiberger, C. E., Vanderjagt, D. J., Pastuszyn, A., Glew, R. S., Mounkaila, G., Millson, M., da Glew, R. H. Kayan abinci mai gina jiki na ganyayyaki masu ci na shuke-shuke bakwai daga Nijar. Abincin Shuka Hum.Nutr. 1998; 53: 57-69. Duba m.
39. Haji, Faraji M. da Haji, Tarkhani A. Tasirin shayi mai tsami (Hibiscus sabdariffa) akan hauhawar jini mai mahimmanci. J.Ethnopharmacol. 1999; 65: 231-236. Duba m.
40. El Basheir, Z. M. da Fouad, M. A. Binciken farko na matukin jirgi a kan kwarkwata, cutar sankara a cikin lardin Sharkia da kuma kula da kwarkwata tare da karin tsirrai. J.Egypt.Soc.Parasitol. 2002; 32: 725-736. Duba m.
41. Kuriyan R, Kumar DR, Rajendran R, Kurpad AV. Bincike game da tasirin kwayar cutar kwayar cutar ta Hibiscus Sabdariffa a cikin Indiyawan Indiya: makafi biyu, gwajin sarrafa wuribo. BMC ya Haɗa Altern Med Med 2010; 10: 27. Duba m.
42. Ngamjarus C, Pattanittum P, Somboonporn C. Roselle don hauhawar jini a cikin manya. Cochrane Database Syst Rev 2010: 1: CD007894. Duba m.
43. McKay DL, Chen CY, Saltzman E, Blumberg JB. Hibiscus Sabdariffa L. shayi (tisane) yana rage hauhawar jini a cikin manya-manya masu rauni na hauhawar jini. Marasa lafiya. J Nutr 2010; 140: 298-303. Duba m.
44. Mohamed R, Fernandez J, Pineda M, Aguilar M. Roselle (Hibiscus sabdariffa) man iri Shine tushen tushen gamma-tocopherol. J Abincin Sci 2007; 72: S207-11.
45. Lin LT, Liu LT, Chiang LC, Lin CC. A cikin vitro anti-hepatoma na magunguna goma sha biyar daga Kanada. Yanayin Phytother Res 2002; 16: 440-4. Duba m.
46. Kolawole JA, Maduenyi A. Sakamakon shan zobo (Hibiscus sabdariffa cire ruwa) akan kantin magani na acetaminophen a cikin masu sa kai na mutane. Eur J Drug Metab Pharmacokinet 2004; 29: 25-9. Duba m.
47. Lambar lantarki na Dokokin Tarayya. Title 21. Kashi na 182 - Abubuwan da Gaba Daya Ganinsu Yana da Lafiya. Akwai a: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
48. Brinker F. Herb Contraindications da Maganganun Miyagun ƙwayoyi. 2nd ed. Sandy, KO: Litattafan Kiwon Lafiyar Jama'a, 1998.
49. Gruenwald J, Brendler T, Jaenicke C. PDR don Magungunan Ganye. 1st ed. Montvale, NJ: Kamfanin tattalin arziki na likitanci, Inc., 1998.
50. Leung AY, Foster S. Encyclopedia na Kayan Abincin Na yau da kullun da Aka Yi Amfani dasu a cikin Abinci, Magunguna da Kayan shafawa. 2nd ed. New York, NY: John Wiley & 'Ya'yan, 1996.

Binciken na ƙarshe - 01/04/2021